Pharmacopsychiatry 1988; 21(3): 147-150
DOI: 10.1055/s-2007-1014667
© Georg Thieme Verlag KG Stuttgart · New York
WHO Pilot Study on the Validity of Imipramine Platelet Receptor Binding Sites as a Biological Marker of Endogenous Depression
A preliminary report on the initial evaluation phase of a World Health Organization Collaborative StudyP. Bech1
, L. Eplov1
, M. Gastpar1
, C. Gentsch1
, J. Mendlewicz1
, P. Plenge1
, C. Rielaert1
, E. T. Mellerup1
-
1The views expressed in this paper are the authors' own and do not necessarily represent the opinions of other
investigators in the WHO Collaborating Centers for Research and Training in Biological Psychiatry nor of the World
Health Organization
-
2The collaborating investigators in this study are: Athens: C. Stefanis, B. Alevisos; Basle: P. Kielholz, M. Gastpar, C.
Gentsch; Brussels: J. Mendlewicz, M. van der Elst, F. Charon, A. Schoutens; Copenhagen: O. J. Rafaelsen, P. Bech,
L. Eplov, E. T. Mellerup; Irvine: W. E. Bunney, S. Potkin; Lucknow: B. B. Sethi; Moscow: M. E. Vartanian, N. Mazaeva;
Munich: H. Hippius, B. Bondy, N. Matussek; Naples: D. Kemali, M. Maj; Tokyo: R. Takhashi, S. Yoshimoto; WHO: P.
Morozov, T. Ngo Khac, L. L. Prilipko
